Velan Capital Investment Management as of Dec. 31, 2024
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 45 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jasper Therapeutics Com New (JSPR) | 26.5 | $31M | 1.4M | 21.38 | |
| Praxis Precision Medicines I Com New (PRAX) | 19.9 | $23M | 300k | 76.96 | |
| Heron Therapeutics (HRTX) | 9.2 | $11M | 7.0M | 1.53 | |
| Tourmaline Bio (TRML) | 7.4 | $8.6M | 424k | 20.28 | |
| Protara Therapeutics Com Stk (TARA) | 7.2 | $8.3M | 1.6M | 5.28 | |
| Springworks Therapeutics (SWTX) | 5.8 | $6.7M | 186k | 36.13 | |
| Rezolute Com New (RZLT) | 3.4 | $3.9M | 800k | 4.90 | |
| Liquidia Corporation Com New (LQDA) | 3.0 | $3.5M | 300k | 11.76 | |
| Zevra Therapeutics Com New (ZVRA) | 2.2 | $2.5M | 300k | 8.34 | |
| Inspiremd (NSPR) | 2.1 | $2.4M | 904k | 2.63 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.0 | $2.3M | 50k | 46.44 | |
| Replimune Group (REPL) | 1.9 | $2.2M | 181k | 12.11 | |
| Nurix Therapeutics (NRIX) | 1.6 | $1.8M | 98k | 18.84 | |
| Perspective Therapeutics Com New (CATX) | 1.4 | $1.6M | 500k | 3.19 | |
| Eledon Pharmaceuticals (ELDN) | 1.2 | $1.3M | 324k | 4.12 | |
| Kura Oncology (KURA) | 1.1 | $1.3M | 150k | 8.71 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.7 | $822k | 29k | 28.65 | |
| Avalo Therapeutics Com New (AVTX) | 0.7 | $817k | 110k | 7.43 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.6 | $669k | 57k | 11.80 | |
| Tenax Therapeutics Com New (TENX) | 0.4 | $516k | 83k | 6.19 | |
| Kiora Pharmaceuticals (KPRX) | 0.3 | $403k | 122k | 3.30 | |
| Geron Corporation (GERN) | 0.1 | $174k | 49k | 3.54 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $161k | 13k | 12.37 | |
| Regulus Therapeutics | 0.1 | $111k | 70k | 1.58 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $107k | 41k | 2.65 | |
| Alector (ALEC) | 0.1 | $104k | 55k | 1.89 | |
| Context Therapeutics (CNTX) | 0.1 | $95k | 90k | 1.05 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $94k | 17k | 5.54 | |
| Ventyx Biosciences (VTYX) | 0.1 | $77k | 35k | 2.19 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $75k | 13k | 5.75 | |
| Larimar Therapeutics (LRMR) | 0.1 | $70k | 18k | 3.87 | |
| Gossamer Bio (GOSS) | 0.1 | $68k | 75k | 0.90 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $67k | 27k | 2.48 | |
| Ovid Therapeutics (OVID) | 0.1 | $65k | 70k | 0.93 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $56k | 10k | 5.57 | |
| Sutro Biopharma (STRO) | 0.0 | $55k | 30k | 1.84 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $53k | 35k | 1.51 | |
| Fibrogen | 0.0 | $42k | 80k | 0.53 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $36k | 35k | 1.03 | |
| Kronos Bio | 0.0 | $33k | 35k | 0.95 | |
| Karyopharm Therapeutics | 0.0 | $27k | 40k | 0.68 | |
| Bolt Biotherapeutics | 0.0 | $27k | 50k | 0.54 | |
| Elevation Oncology (ELEV) | 0.0 | $25k | 45k | 0.56 | |
| Cocrystal Pharma Com New (COCP) | 0.0 | $20k | 10k | 2.02 | |
| Nextcure (NXTC) | 0.0 | $19k | 25k | 0.77 |
